Abstract
Background: Neurological soft signs (NSS), i.e. subtle neurological abnormalities, have been frequently found in schizophrenia. Neuroimaging studies in schizophrenia have shown abnormal cortical thickness changes across the cortical mantle. However, few studies have examined relationships between NSS and cortical thickness abnormalities in schizophrenia. Method: A sample of 18 patients with chronic schizophrenia and 20 age-matched healthy controls were included. Cortical thickness was assessed on high-resolution 3-tesla magnetic resonance imaging by using FreeSurfer software and NSS were rated on the Heidelberg Scale. Results: Significant negative correlations between NSS and cortical thickness were found in the prefrontal, inferior temporal, superior parietal, postcentral, and supramarginal cortices in the schizophrenia patients. In the controls, however, this negative correlation was found in the anterior cingulate, pericalcarine and superior/middle temporal regions. Conclusion: Our results not only confirmed the association between NSS and cortical thickness in chronic schizophrenia but also indicated that patients and controls have different anatomical substrates of NSS.
References
1.
Andreasen NC, Paradiso S, O'Leary DS: ‘Cognitive dysmetria' as an integrative theory of schizophrenia. Schizophr Bull 1998;24:203-218.
2.
Heinrichs DW, Buchanan RW: Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 1988;145:11-18.
3.
Schröder J, Niethammer R, Geider F-J, et al: Neurological soft signs in schizophrenia. Schizophr Res 1991;6:25-30.
4.
Cox SM, Ludwig AM: Neurological soft signs and psychopathology. I. Findings in schizophrenia. J Nerv Ment Dis 1979;167:161-165.
5.
Rochford JM, Detre T, Tucker GJ, Harrow M: Neuropsychological impairments in functional psychiatric diseases. Arch Gen Psychiatry 1970;22:114-119.
6.
Thomann P, Wüstenberg T, Santos VD, Bachmann S, Essig M, Schröder J: Neurological soft signs and brain morphology in first-episode schizophrenia. Psychol Med 2009;39:371-379.
7.
Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS: Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia. Psychiatry Res 2008;164:215-222.
8.
Winkler AM, Kochunov P, Blangero J, et al: Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 2010;53:1135-1146.
9.
Dale AM, Fischl B, Sereno MI: Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999;9:179-194.
10.
Fischl B, Sereno MI, Dale AM: Cortical surface-based analysis. II. Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9:195-207.
11.
Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, et al: Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. Psychol Med 2011;41:1449-1460.
12.
Schultz CC, Koch K, Wagner G, et al: Reduced cortical thickness in first episode schizophrenia. Schizophr Res 2010;116:204-209.
13.
Narr KL, Bilder RM, Toga AW, et al: Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex 2005;15:708-719.
14.
Narr KL, Toga AW, Szeszko P, et al: Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry 2005;58:32-40.
15.
Nesvåg R, Lawyer G, Varnäs K, et al: Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res 2008;98:16-28.
16.
Schultz CC, Koch K, Wagner G, et al: Complex pattern of cortical thinning in schizophrenia: results from an automated surface based analysis of cortical thickness. Psychiatry Res 2010;182:134-140.
17.
Hirjak D, Wolf RC, Stieltjes B, et al: Neurological soft signs and brainstem morphology in first-episode schizophrenia. Neuropsychobiology 2013;68:91-99.
18.
Dazzan P, Morgan KD, Chitnis X, et al: The structural brain correlates of neurological soft signs in healthy individuals. Cereb Cortex 2006;16:1225-1231.
19.
Hirjak D, Wolf RC, Stieltjes B, et al: Cortical signature of neurological soft signs in recent onset schizophrenia. Brain Topogr 2014;27:296-306.
20.
Schröder J, Buchsbaum MS, Siegel BV, et al: Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 1996;19:41-53.
21.
Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
22.
Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E: The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008;165:1015-1023.
23.
Herold CJ, Lässer MM, Schmid LA, et al: Hippocampal volume reduction and autobiographical memory deficits in chronic schizophrenia. Psychiatry Res 2013;211:189-194.
24.
Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M: SKID-I: Strukturiertes klinisches Interview für DSM-IV. Göttingen, Hogrefe, 1997.
25.
Woods SW: Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667.
26.
Fischl B, Dale AM: Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050-11055.
27.
Fischl B, Sereno MI, Tootell RB, Dale AM: High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999;8:272-284.
28.
Segonne F, Dale AM, Busa E, et al: A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004;22:1060-1075.
29.
Sled JG, Zijdenbos AP, Evans AC: A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998;17:87-97.
30.
Fischl B, Liu A, Dale AM: Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 2001;20:70-80.
31.
Segonne F, Pacheco J, Fischl B: Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 2007;26:518-529.
32.
Kuperberg GR, Broome MR, McGuire PK, et al: Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003;60:878-888.
33.
Honea R, Crow TJ, Passingham D, Mackay CE: Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005;162:2233-2245.
34.
Williams LM: Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect. Expert Rev Neurother 2008;8:1049-65.
35.
Buckner RL, Andrews-Hanna JR, Schacter DL: The brain's default network: anatomy, function, and relevance to disease. Ann NY Acad Sci 2008;1124:1-38.
36.
Crespo-Facorro B, Kim J-J, Andreasen NC, O'Leary DS, Bockholt HJ, Magnotta V: Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res 2000;46:35-43.
37.
Dazzan P, Morgan KD, Orr KG, et al: The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 2004;127:143-153.
38.
Kong L, Bachmann S, Thomann PA, Essig M, Schröder J: Neurological soft signs and gray matter changes: a longitudinal analysis in first-episode schizophrenia. Schizophr Res 2012;134:27-32.
39.
Calvert GA: Crossmodal processing in the human brain: insights from functional neuroimaging studies. Cereb Cortex 2001;11:1110-1123.
40.
DeLong M: The basal ganglia; in Kandel E, Schwartz J, Jessel TM (eds): Principles of Neural Science. New York, McGraw-Hill, 2000, pp 853-867.
41.
Schröder J, Essig M, Baudendistel K, et al: Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. Neuroimage 1999;9:81-87.
42.
Schröder J, Wenz F, Schad L, Baudendistel K, Knopp M: Sensorimotor cortex and supplementary motor area changes in schizophrenia: a study with functional magnetic resonance imaging. Br J Psychiatry 1995;167:197-201.
43.
Barkus E, Stirling J, Hopkins R, Lewis S: The presence of neurological soft signs along the psychosis proneness continuum. Schizophr Bull 2006;32:573-577.
44.
Blondis TA, Snow JH, Accardo PJ: Integration of soft signs in academically normal and academically at-risk children. Pediatrics 1990;85:421-425.
45.
Breslau N, Chilcoat HD, Johnson EO, Andreski P, Lucia VC: Neurologic soft signs and low birthweight: their association and neuropsychiatric implications. Biol Psychiatry 2000;47:71-79.
46.
Ridler K, Veijola JM, Tanskanen P, et al: Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci USA 2006;103:15651-15656.
47.
Thompson PM, Vidal C, Giedd JN, et al: Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 2001;98:11650-11655.
48.
Daskalakis ZJ, Christensen BK, Fitzgerald PB, Chen R: Dysfunctional neural plasticity in patients with schizophrenia. Arch Gen Psychiatry 2008;65:378-385.
49.
Rakic P: Specification of cerebral cortical areas. Science 1988;241:170-176.
50.
Kong L, Herold C, Stieltjes B, et al: Reduced gray to white matter tissue intensity contrast in schizophrenia. PLoS one 2012;7:e37016.
51.
Salat DH, Lee SY, van der Kouwe AJ, Greve DN, Fischl B, Rosas HD: Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. Neuroimage 2009;48:21-28.
52.
Schröder J, Silvestri S, Bubeck B, et al: D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry 1998;43:660-665.
53.
Buchanan RW, Heinrichs DW: The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989;27:335-350.
54.
Chen EY, Shapleske J, Luque R, et al: The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res 1995;56:183-204.
55.
Bachmann S, Bottmer C, Schröder J: Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 2005;162:2337-2343.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
